CDKN2A and plasma cell myeloma: Moreover, methylation of BM742401 correlated with shorter OS in newly diagnosed myeloma, similar to CDKN2A [44, 45] and DAPK1 [46] methylation, suggesting an adverse impact of BM742401 methylation for OS.